Stocks / Biotech
GMABBiotech
Genmab A/S ADS
$34.401d +0.7%5d +3.8%settled close · 2026-09-16
Who’s talkingIdea Scout · free
Who’s talking about GMAB
No tracked investor commentary on GMAB yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where GMAB’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 11 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-16 | ||||||
| 2026-09-15 | ||||||
| 2026-08-26 | ||||||
| 2026-08-20 | ||||||
| 2026-08-14 | ||||||
| 2026-08-07 | ||||||
| 2026-08-06 | ||||||
| 2026-08-04 | ||||||
| 2026-06-29 | ||||||
| 2026-06-25 | ||||||
| 2026-06-23 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
GMAB is in this morning’s Brief.
Get The Brief — $20/mo →